Adrian Woolfson is the founder of Replay. Replay has raised $55M in total funding. Latest round: Seed. Backed by KKR, OMX Ventures, ARTIS Ventures.
Adrian Woolfson is a co-founder, Executive Chairman, and President of Replay, a genome writing company that launched with $55 million in seed financing. Replay focuses on reprogramming biology by writing and delivering big DNA, utilizing technologies such as a high-payload capacity HSV delivery platform and a proprietary genome writing platform. Prior to co-founding Replay, Woolfson held leadership positions at Sangamo Therapeutics, Nouscom, Pfizer, and Bristol Myers Squibb.
Full founder directory · Investor directory · Company funding database · Fundraising library